SNRNP200-related dominant retinopathy (retinitis pigmentosa 33, RP33) is an autosomal dominant rod-cone degeneration caused by heterozygous missense variants in SNRNP200, which encodes Brr2, the U5 snRNP RNA helicase that unwinds the U4/U6 snRNA duplex to activate the spliceosome. Recurrent variants such as p.Ser1087Leu and p.Arg1090Leu sit in the ratchet helix of the first helicase cassette. The mutant helicase still assembles into spliceosomes but unwinds U4/U6 poorly, and its loss of function at 5' splice-site recognition lets cryptic sites be used. Patients present with night blindness, usually in the first two decades, and a rod-predominant dystrophy that later involves cones. Onset and severity vary widely and penetrance is incomplete. SNRNP200 accounts for about 1.6 percent of autosomal dominant retinitis pigmentosa, and its course is milder on average than PRPF-gene retinopathy.
Ask a research question about SNRNP200-Related Dominant Retinopathy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: SNRNP200-Related Dominant Retinopathy
creation_date: "2026-10-25T00:00:00Z"
category: Mendelian
description: >-
SNRNP200-related dominant retinopathy (retinitis pigmentosa 33, RP33) is an
autosomal dominant rod-cone degeneration caused by heterozygous missense
variants in SNRNP200, which encodes Brr2, the U5 snRNP RNA helicase that
unwinds the U4/U6 snRNA duplex to activate the spliceosome. Recurrent
variants such as p.Ser1087Leu and p.Arg1090Leu sit in the ratchet helix of
the first helicase cassette. The mutant helicase still assembles into
spliceosomes but unwinds U4/U6 poorly, and its loss of function at 5'
splice-site recognition lets cryptic sites be used. Patients present with
night blindness, usually in the first two decades, and a rod-predominant
dystrophy that later involves cones. Onset and severity vary widely and
penetrance is incomplete. SNRNP200 accounts for about 1.6 percent of
autosomal dominant retinitis pigmentosa, and its course is milder on
average than PRPF-gene retinopathy.
disease_term:
preferred_term: SNRNP200-related dominant retinopathy
term:
id: MONDO:0800098
label: SNRNP200-related dominant retinopathy
synonyms:
- Retinitis pigmentosa 33
- RP33
- SNRNP200 retinitis pigmentosa
- BRR2-associated retinitis pigmentosa
parents:
- Ophthalmological Disease
- Retinal Dystrophy
- Inherited retinal dystrophy
- Spliceosomopathy
mappings:
mondo_mappings:
- term:
id: MONDO:0012477
label: retinitis pigmentosa 33
mapping_predicate: skos:narrowMatch
mapping_source: MONDO
notes: >-
Retinitis pigmentosa 33 is the classically named clinical entity and the
only MONDO child of the SNRNP200 gene-series term used as this entry's
disease_term.
inheritance:
- name: Autosomal dominant inheritance
inheritance_term:
preferred_term: Autosomal dominant inheritance
term:
id: HP:0000006
label: Autosomal dominant inheritance
description: >-
Heterozygous variants with variable onset and severity and occasional
non-penetrance.
evidence:
- reference: PMID:19878916
reference_title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The c.3260C>T substitution showed complete cosegregation with the retinitis pigmentosa (RP) phenotype over four generations, but was absent in a panel of 400 controls."
explanation: Dominant segregation over four generations in the founding family.
- reference: PMID:24319334
reference_title: "Mutations in the small nuclear riboprotein 200 kDa gene (SNRNP200) cause 1.6% of autosomal dominant retinitis pigmentosa."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Clinical examination of patients with SNRNP200 mutations showed a wide range of clinical symptoms and severity, including one instance of non-penetrance."
explanation: Variable expressivity and non-penetrance.
pathophysiology:
- name: SNRNP200 Missense Variant in the Brr2 Helicase Cassette
conforms_to: "spliceosome_component_dysfunction#Germline Spliceosome Component Variant"
description: >-
Heterozygous missense variants concentrate in exons 16 and 25. The
recurrent p.Ser1087Leu and p.Arg1090Leu lie in the ratchet helix of the
first Sec63 domain, which governs directional unwinding.
biological_scale: MOLECULAR
genes:
- preferred_term: SNRNP200
term:
id: hgnc:30859
label: SNRNP200
molecular_functions:
- preferred_term: RNA helicase activity
term:
id: GO:0003724
label: RNA helicase activity
cellular_components:
- preferred_term: U4/U6.U5 tri-snRNP
term:
id: GO:0046540
label: U4/U6 x U5 tri-snRNP complex
evidence:
- reference: PMID:19878916
reference_title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The p.S1087L mutation and p.R1090L, another adRP-associated allele, reside in the \"ratchet\" helix of the first of two Sec63 domains implicated in the directionality and processivity of nucleic acid unwinding."
explanation: Locates the recurrent variants in the helicase ratchet helix.
- reference: PMID:24319334
reference_title: "Mutations in the small nuclear riboprotein 200 kDa gene (SNRNP200) cause 1.6% of autosomal dominant retinitis pigmentosa."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Pathogenic mutations were found primarily in exons 16 and 25"
explanation: Variant clustering in a US cohort.
downstream:
- target: Impaired Brr2 U4/U6 Unwinding
causal_link_type: DIRECT
- name: Impaired Brr2 U4/U6 Unwinding
description: >-
RP variants weaken Brr2 RNA binding, ATPase and helicase activity and alter
how Brr2 contacts U4 and U6 in the spliceosome, so U4/U6 is unwound
inefficiently at activation. The mutant protein still assembles into snRNPs
and spliceosomes, so this is an altered-function defect within the
machine rather than a shortage of it.
biological_scale: MOLECULAR
molecular_functions:
- preferred_term: Brr2 RNA helicase activity
term:
id: GO:0003724
label: RNA helicase activity
modifier: DECREASED
biological_processes:
- preferred_term: U4/U6 release during spliceosome activation
term:
id: GO:0000388
label: spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)
modifier: DECREASED
evidence:
- reference: PMID:27072132
reference_title: "Retinitis Pigmentosa Mutations in Bad Response to Refrigeration 2 (Brr2) Impair ATPase and Helicase Activity."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The Δ247-Brr2 RP mutants exhibit a gradient of severity of weakened RNA binding, reduced helicase activity, and reduced ATPase activity compared with wild type Δ247-Brr2."
explanation: Purified Brr2 RP mutants are deficient helicases.
- reference: PMID:40045025
reference_title: "Retinitis pigmentosa-linked mutations impair the snRNA unwinding activity of SNRNP200 and reduce pre-mRNA binding of PRPF8."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The significantly broader binding profile of mutated SNRNP200 within the U4 region upstream of the U4/U6 stem I strongly suggests that its activity to unwind snRNAs is impaired."
explanation: iCLIP in HeLa and RPE cells shows altered U4 binding by mutant SNRNP200.
- reference: PMID:19878916
reference_title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "marked defects in U4/U6 unwinding, but not U4/U6-U5 snRNP assembly, were observed in budding yeast for the analogous mutations (N1104L and R1107L) of the corresponding Brr2p residues"
explanation: Yeast equivalents unwind poorly but assemble normally.
- reference: PMID:24302620
reference_title: "Retinitis pigmentosa mutations of SNRNP200 enhance cryptic splice-site recognition."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Mutations in BRR2 did not compromise snRNP assembly and both mutants were incorporated into the spliceosome just as the wild-type (wt) protein."
explanation: Mutant Brr2 is incorporated normally in human cells.
downstream:
- target: Defective 5' Splice-Site Recognition with Cryptic Site Use
causal_link_type: DIRECT
- name: Defective 5' Splice-Site Recognition with Cryptic Site Use
conforms_to: "spliceosome_component_dysfunction#Mis-Splicing of a Sensitive Transcript Subset"
description: >-
In human cells, losing wild-type Brr2 increases use of a cryptic 5' splice
site at the expense of the correct one, and the RP mutants cannot restore
correct site choice, so the variants impair Brr2's role in 5' splice-site
recognition. Which retinal transcripts are affected has not been mapped.
biological_scale: CELLULAR
biological_processes:
- preferred_term: mRNA 5'-splice site recognition
term:
id: GO:0000395
label: mRNA 5'-splice site recognition
modifier: ABNORMAL
evidence:
- reference: PMID:24302620
reference_title: "Retinitis pigmentosa mutations of SNRNP200 enhance cryptic splice-site recognition."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Proper splicing of optimal and cryptic splice sites was restored in cells expressing BRR2-wt but not in cells expressing RP mutants."
explanation: RP mutants fail to restore correct splice-site choice.
- reference: PMID:24302620
reference_title: "Retinitis pigmentosa mutations of SNRNP200 enhance cryptic splice-site recognition."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Taken together, our data suggest that BRR2 is an important factor in 5'-splice-site recognition and that the RP-linked mutations c.3260C>T (p.S1087L) and c.3269G>T (p.R1090L) affect this BRR2 function."
explanation: Places the defect at 5' splice-site recognition.
downstream:
- target: Photoreceptor Dysfunction and Degeneration
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Photoreceptor Dysfunction and Degeneration
conforms_to: "spliceosome_component_dysfunction#Failure of Splicing-Sensitive Cell Populations"
description: >-
Rods fail first and cones later. In Drosophila carrying human RP
substitutions in Snrnp200, photoreceptors are mispatterned and
electrophysiologically abnormal, with mitochondrial defects and altered
redox-gene expression; in zebrafish, the mutant but not the wild-type
human protein injures the retina.
biological_scale: CELLULAR
cell_types:
- preferred_term: rod photoreceptor
term:
id: CL:0000604
label: retinal rod cell
- preferred_term: cone photoreceptor
term:
id: CL:0000573
label: retinal cone cell
evidence:
- reference: PMID:42593897
reference_title: "N-acetylcysteine suppresses retinal defects in Drosophila models of SNRNP200-associated retinitis pigmentosa."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "When human RP-causing mutations were modeled in Drosophila Snrnp200, they resulted in abnormal retinal electrophysiology and defective patterning of photoreceptors."
explanation: Photoreceptor defects from RP substitutions in the fly orthologue.
- reference: PMID:42593897
reference_title: "N-acetylcysteine suppresses retinal defects in Drosophila models of SNRNP200-associated retinitis pigmentosa."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Further analysis of the photoreceptors revealed mitochondrial defects and altered expression of genes related to redox homeostasis."
explanation: Mitochondrial and redox changes in mutant photoreceptors.
- reference: PMID:33553197
reference_title: "SNRNP200 Mutations Cause Autosomal Dominant Retinitis Pigmentosa."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Overexpression of SNRNP200Arg2030Cys, but not SNRNP200WT caused systemic deformities in the wild-type zebrafish embryos with the retina primarily injured"
explanation: >-
The mutant protein is harmful on a wild-type background, consistent with
an altered-function or dominant-negative effect.
downstream:
- target: Night blindness
- target: Rod-cone dystrophy
- target: Abnormal electroretinogram
phenotypes:
- name: Night blindness
category: Ophthalmological
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Night blindness
term:
id: HP:0000662
label: Nyctalopia
evidence:
- reference: PMID:31486839
reference_title: "Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "each presented with nyctalopia, typically in the first 2 decades of life, although 2 patients experienced symptom onset in middle age"
explanation: Nyctalopia in all nine patients, usually early.
- reference: PMID:31260034
reference_title: "Genotype-Phenotype Analysis of a Novel Recessive and a Recurrent Dominant SNRNP200 Variant Causing Retinitis Pigmentosa."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Nyctalopia and photophobia were reported by 6/6 and 2/6 patients, respectively."
explanation: Nyctalopia in all six patients.
- name: Rod-cone dystrophy
category: Ophthalmological
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Rod-predominant dystrophy
term:
id: HP:0000510
label: Rod-cone dystrophy
evidence:
- reference: PMID:31486839
reference_title: "Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Retinal imaging studies and electroretinography findings were typical of a rod-predominant dystrophy with later involvement of cone photoreceptors."
explanation: Rod-cone pattern on imaging and ERG.
- name: Abnormal electroretinogram
category: Ophthalmological
phenotype_term:
preferred_term: Diminished electroretinogram
term:
id: HP:0000512
label: Abnormal electroretinogram
evidence:
- reference: PMID:31486839
reference_title: "Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Retinal imaging studies and electroretinography findings were typical of a rod-predominant dystrophy with later involvement of cone photoreceptors."
explanation: ERG abnormality in nine SNRNP200 patients.
- name: Reduced visual acuity
category: Ophthalmological
phenotype_term:
preferred_term: Reduced visual acuity
term:
id: HP:0007663
label: Reduced visual acuity
evidence:
- reference: PMID:31260034
reference_title: "Genotype-Phenotype Analysis of a Novel Recessive and a Recurrent Dominant SNRNP200 Variant Causing Retinitis Pigmentosa."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "disease severity (visual acuity of 20/20-20/200 in the seventh to eighth decade)"
explanation: Acuity ranges from normal to 20/200 late in life with the dominant variant.
- name: Spicular pigmentation of the retina
category: Ophthalmological
phenotype_term:
preferred_term: Bone spicule pigmentation
term:
id: HP:0007737
label: Spicular pigmentation of the retina
evidence:
- reference: PMID:19878916
reference_title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Consistently, bone-spicule-like pigmentary deposits were observed in the local peripheral retina of both eyes during funduscopy (Figure 2D)."
explanation: Bone-spicule pigment in an affected member of the founding family.
genetic:
- name: SNRNP200
gene_term:
preferred_term: SNRNP200
term:
id: hgnc:30859
label: SNRNP200
association: >-
Causative heterozygous missense variants, mostly in the first helicase
cassette.
relationship_type: CAUSATIVE
variant_origin: GERMLINE
case_fractions:
- population: A well-characterized cohort of 251 autosomal dominant retinitis pigmentosa families
case_fraction_percent: 1.6
cohort_size: 251
evidence:
- reference: PMID:24319334
reference_title: "Mutations in the small nuclear riboprotein 200 kDa gene (SNRNP200) cause 1.6% of autosomal dominant retinitis pigmentosa."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Mutations in SNRNP200 caused 1.6% of disease in our adRP cohort."
explanation: >-
SNRNP200 share of adRP in the 251-family cohort; the 21 additional
eyeGENE families tested in the same study are not part of this
figure.
gene_disease_validity:
- validity_classification: DEFINITIVE
classified_by: CLINGEN
external_id: CGGV:assertion_41acb15c-18a0-412b-a308-66a7f4e2837a-2022-05-24T160000.000Z
evidence:
- reference: CGGV:assertion_41acb15c-18a0-412b-a308-66a7f4e2837a-2022-05-24T160000.000Z
reference_title: "SNRNP200 / SNRNP200-related dominant retinopathy (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "SNRNP200 | HGNC:30859 | SNRNP200-related dominant retinopathy | MONDO:0800098 | AD | Definitive"
explanation: ClinGen gene-disease validity record classifying this pair as Definitive.
evidence:
- reference: PMID:19878916
reference_title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here, we report the identification of a missense mutation, c.3260C>T (p.S1087L), in exon 25 of the SNRNP200 gene in an RP33-linked family."
explanation: Founding gene-disease report.
- reference: PMID:19710410
reference_title: "Mutations in ASCC3L1 on 2q11.2 are associated with autosomal dominant retinitis pigmentosa in a Chinese family."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Sequencing of ASCC3L1 in an affected family member showed a heterozygous single-base-pair change; c.3269G-->T, predicted to result in an Arg1090Leu amino acid change."
explanation: Independent family with the second recurrent variant, under the former gene symbol ASCC3L1.
- reference: CGGV:assertion_41acb15c-18a0-412b-a308-66a7f4e2837a-2022-05-24T160000.000Z
reference_title: "SNRNP200 / SNRNP200-related dominant retinopathy (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "SNRNP200 | HGNC:30859 | SNRNP200-related dominant retinopathy | MONDO:0800098 | AD | Definitive"
explanation: ClinGen Definitive classification for this disease.
animal_models:
- name: Drosophila Snrnp200 RP knock-in
species: Fruit fly
genotype: Human RP substitutions introduced into Drosophila Snrnp200
publication: PMID:42593897
modeled_mechanisms:
- target: Photoreceptor Dysfunction and Degeneration
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
model_scale: CELLULAR
description: >-
Reproduces photoreceptor patterning and electrophysiology defects from
the human substitutions in the conserved orthologue.
limitations: >-
The fly compound eye differs from the vertebrate retina, with no rod-cone
distinction and no retinal pigment epithelium, so the rod-first course of
the human disease cannot be tested.
evidence:
- reference: PMID:42593897
reference_title: "N-acetylcysteine suppresses retinal defects in Drosophila models of SNRNP200-associated retinitis pigmentosa."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "When human RP-causing mutations were modeled in Drosophila Snrnp200, they resulted in abnormal retinal electrophysiology and defective patterning of photoreceptors."
explanation: The model's photoreceptor phenotype.
treatments:
- name: Genetic Counseling
description: >-
Counseling for a dominant disorder with variable onset and occasional
non-penetrance.
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
discussions:
- discussion_id: snrnp200_altered_function_or_dominant_negative
kind: OPEN_QUESTION
status: OPEN
attaches_to:
- pathophysiology#Impaired Brr2 U4/U6 Unwinding
prompt: >-
Does mutant Brr2 cause disease by sitting in spliceosomes as a weak
helicase, or by actively interfering with the wild-type protein?
rationale: >-
The RP mutants assemble into spliceosomes like wild type yet unwind U4/U6
poorly and fail at 5' splice-site recognition, which fits a partly active
helicase competing for spliceosome slots. In zebrafish the mutant human
protein, but not the wild-type one, injures the retina on a normal
background, which suggests a toxic or dominant-negative effect. No study has
titrated mutant against wild-type Brr2 in human retinal cells, which is
what would decide whether lowering the mutant allele could help.
evidence:
- reference: PMID:33553197
reference_title: "SNRNP200 Mutations Cause Autosomal Dominant Retinitis Pigmentosa."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Overexpression of SNRNP200Arg2030Cys, but not SNRNP200WT caused systemic deformities in the wild-type zebrafish embryos with the retina primarily injured"
explanation: Evidence for a harmful effect of the mutant protein itself.
references:
- reference: PMID:19878916
title: "Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs."
- reference: PMID:24319334
title: "Mutations in the small nuclear riboprotein 200 kDa gene (SNRNP200) cause 1.6% of autosomal dominant retinitis pigmentosa."
notes: >-
A homozygous SNRNP200 missense variant (p.Arg545His) causing recessive
retinitis pigmentosa with distinct dot-like hypopigmentation is described in
PMID:31260034; this entry covers the dominant disease only, and the
photophobia that study reports pools the dominant family with the recessive
patient, so it is not curated here. In an Irish cohort, variants in the PRPF
genes caused more severe retinal degeneration than SNRNP200 variants
(PMID:42405195). ClinGen's evidence summary lists attenuated vessels, optic
disc pallor and macular degeneration among general retinitis pigmentosa
features; they are not curated here without an SNRNP200 patient source. No GeneReviews
chapter is specific to SNRNP200.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Scope and verification status. I could reach PubMed search listings, a Frontiers full-text page, and web-search summaries. PubMed abstract pages returned 429 or cookie walls. A script to pull abstracts from Europe PMC needed an approval that did not come through, so I did not run it. Consequences:
- PMIDs below come from a PubMed result list (title, first author, journal, year). That list shows titles only, so PMIDs are reliable but content descriptions of papers I did not open are inferred from titles.
- The only verbatim quote I confirmed is one sentence from Zhang 2021 (Section 3). Everything else is paraphrase and is marked as such.
- Items marked [unverified] need checking before they go into the KB. Run just fetch-reference PMID:… and copy exact snippets from the cache.
runoak before binding. If MONDO:0800098 is a gene-defined "SNRNP200-related" umbrella term, check the lump/split and mappings.mondo_mappings predicate (exactMatch or narrowMatch only retire the stub).Grouping entry, not for lumping.Clinical features. The terms below are suggested from MedGen's HPO listing for RP33 and from general adRP knowledge. Percentages, onset and severity are not extracted. Frequency data would come from PMID:31486839 (Yusuf 2019, JAMA Ophthalmol, "Clinical characterization of RP with SNRNP200 variants"), which I did not read.
| Phenotype | Suggested HPO | Notes |
|---|---|---|
| Night blindness (nyctalopia) | HP:0000662 | Early symptom; MedGen lists it |
| Rod-cone dystrophy / retinitis pigmentosa | HP:0000510 | Core feature |
| Optic disc pallor | HP:0000543 | MedGen lists it |
| Constriction of peripheral visual field | HP:0001133 | Expected in adRP |
| Reduced or absent ERG | HP:0000550 / HP:0000512 | Expected |
| Bone-spicule retinal pigmentation | HP:0007737 | Expected |
| Reduced visual acuity | HP:0007663 | Late |
All HPO CURIEs are from memory and must be looked up before use.
hgnc:30[unverified, look up]), OMIM 601664, 2q11.2.just check-gene-validity.functional_impact_category carefully (e.g. DOMINANT_NEGATIVE only if a source states it).Not applicable. No toxins, lifestyle factors or infectious agents are reported as contributors. Separately, SNRNP200 has a role in viral RNA sensing and IRF3 activation (Tremblay 2016, PMID:27454487). That is an immune function of the protein, not an infectious cause of the retinopathy.
Causal chain (steps marked inferred are not directly demonstrated in patient retina):
Open questions. Why a ubiquitous protein harms mainly the retina is unresolved. Tissue-specificity reviews are PMID:40264708 (Kemal 2025) and PMID:27302685. A Brr2–Prp8 interaction is relevant, because the Prp8 C-terminal tail inhibits Brr2 (Mozaffari-Jovin 2013, PMID:23704370), and the Zimmann 2025 title concerns SNRNP200 variants and PRPF8 binding. Mozaffari-Jovin 2014 (PMID:24643059) covers Brr2 regulation and retinal disease.
Suggested ontology terms (look up before use; GO IDs from memory): - GO: mRNA splicing, via spliceosome (GO:0000398); U4/U6 x U5 tri-snRNP complex (GO:0046540); RNA helicase activity (GO:0003724). - CL: retinal rod cell (CL:0000604); retinal pigment epithelial cell (CL:0002586); retinal cone cell (CL:0000573). - No transcriptomic, proteomic or metabolomic patient datasets were found. Zimmann 2025 contains iCLIP data from HeLa and RPE cells.
No survival effect (nonsyndromic). Expected outcome is progressive vision loss with legal blindness in many older patients. Complications likely include cataract and cystoid macular edema, as in RP generally [unverified for this gene]. Genotype-specific prognosis is the focus of Yusuf 2019.
Genetic counselling and cascade testing; prenatal or preimplantation diagnosis is possible for a known familial variant. No primary prevention exists.
No naturally occurring disease linked to SNRNP200 was found in my searches. I did not check OMIA. Orthologs exist in all model species below (NCBI Gene IDs not looked up).
animal_models for zebrafish, Drosophila and C. elegans, with modeled_mechanisms links. Use experimental_models for cell lines and iPSC. Cell-line splicing data should carry evidence_source: IN_VITRO.Grouping, and a module for spliceosome function (check just list-modules splic first).Checked with linkml-reference-validator 0.3.0.
| Outcome | Count |
|---|---|
| References checked | 36 |
| Resolved | 36 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 36 |
| On topic | 32 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 25 |
| Resolved | 24 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 1 |
| Terms whose name was checked | 8 |
| Terms named correctly | 3 |
| Terms named as a different term | 0 |
| Terms whose name is worth a second look | 5 |
The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0000662 (1 mention) - the report calls it "Night blindness (nyctalopia)"; HP calls it Nyctalopia, and lists "Night blindness" among its other namesHP:0000510 (1 mention) - the report calls it "Rod-cone dystrophy / retinitis pigmentosa"; HP calls it Rod-cone dystrophy, and lists "Retinitis pigmentosa" among its other namesHP:0007737 (1 mention) - the report calls it "Bone-spicule retinal pigmentation"; HP calls it Spicular pigmentation of the retina, and lists "Bone corpuscle fundus pigmentation" among its other namesGO:0000398 (1 mention) - the report calls it "GO: mRNA splicing, via spliceosome"; GO calls it mRNA splicing, via spliceosomeCL:0000604 (1 mention) - the report calls it "CL: retinal rod cell"; CL calls it retinal rod cellTerms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: OMIM.
24 of 25 terms resolved to a current term; the rest could not be looked up either way.